Invitae Corporation is a medical genetics enterprise focused on integrating genetic insights into mainstream healthcare to improve patient outcomes across the United States, Canada, and internationally. The company delivers an extensive suite of genetic tests covering diverse clinical domains, including inherited cancers, cardiac health, neurological disorders, pediatric conditions, general oncology, metabolic diseases, and rare illnesses. Beyond testing, they also offer digital health platforms and health data services.